Specialty Injectable Generics Market contains market size and forecasts of Specialty Injectable Generics in Global, including the following market information:
- Global Specialty Injectable Generics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Specialty Injectable Generics market was valued at 10220 million in 2021 and is projected to reach US$ 17560 million by 2028, at a CAGR of 8.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Type I Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Specialty Injectable Generics include Pfizer, Fresenius, Mylan, Teva Pharmaceutical, Hikma Pharmaceuticals, Novartis, Uman Pharma, Baxter and Par Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Specialty Injectable Generics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Specialty Injectable Generics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Specialty Injectable Generics Market Segment Percentages, by Type, 2021 (%)
Global Specialty Injectable Generics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Specialty Injectable Generics Market Segment Percentages, by Application, 2021 (%)
- Oncology
- Cardiovascular
- Central Nervous System
- Infectious Diseases
- Autoimmune Disorders
Global Specialty Injectable Generics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Specialty Injectable Generics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Specialty Injectable Generics revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Specialty Injectable Generics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Fresenius
- Mylan
- Teva Pharmaceutical
- Hikma Pharmaceuticals
- Novartis
- Uman Pharma
- Baxter
- Par Pharmaceutical
- Sagent Pharmaceuticals
- Teligent
Industry Market Size
